Date: 19.6.2020
Summary:
A German university offers chimeric mutants of interferon alpha 2 and other interferon alpha subtypes with improved antiviral activity for treatment of chronic or acute viral infections, bacterial or parasitic infections or tumour therapy. These interferons are characterized by a high biocompatibility. The university offers license agreements.
Reference: TODE20200519003
Country: Germany
Submitted: 19. 6. 2020
Keywords
Technology: Cytology, Cancerology, Oncology; Pharmaceutical Products / Drugs; Virus, Virology/Antibiotics/Bacteriology
Market: Oncology; Other clinical medicine; Pharmaceuticals/fine chemicals
NACE: -
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
OECD Biotechnology Topic - Organisation for Economic Co-operation and Development
Africa Biotech - Biotechnology and African Agriculture news
Researchers uncover key biomolecule involved in whooping cough infection
Mussel-inspired adhesive builds a bond between implants and bones